Article
Targeted Therapies for Slow‐Flow Vascular Malformations
17 Mar 2025
Abstract excerpt
Advances in genetic sequencing technologies have enabled the identification of key activating somatic variants in cellular signalling pathways involved in the pathogenesis of vascular malformations. Given that these genetic variants are also implicated in the pathogenesis of several cancers, the repurposing of targeted therapies developed in oncology has been increasingly investigated for treating vascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
